This paper reports on the consensus conference on the management of intra-abdominal infections (IAIs) which was held on July 23, 2016, in Dublin, Ireland, as a part of the annual World Society of Emergency Surgery (WSES) meeting. This document covers all aspects of the management of IAIs. The Grading of Recommendations Assessment, Development and Evaluation recommendation is used, and this document represents the executive summary of the consensus conference findings.

• Klíčová slova
• Antibiotics, Intra-abdominal infections, Peritonitis, Sepsis,
• MeSH
• antibakteriální látky terapeutické užití   MeSH
• apendektomie metody   MeSH
• bolesti břicha etiologie   MeSH
• cholecystektomie laparoskopická metody   MeSH
• divertikulitida chirurgie   MeSH
• laparoskopie metody   statistika a číselné údaje   MeSH
• lidé MeSH
• metody pro podporu rozhodování MeSH
• nitrobřišní hypertenze etiologie   prevence a kontrola   MeSH
• nitrobřišní infekce komplikace   chirurgie   MeSH
• počítačová rentgenová tomografie metody   MeSH
• směrnice jako téma * MeSH
• ultrasonografie metody   MeSH
• vyhodnocení orgánové dysfunkce MeSH
• výsledek terapie MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• konsensus - konference MeSH
• přehledy MeSH
• Názvy látek
• antibakteriální látky MeSH

Intra-abdominal infections (IAI) are an important cause of morbidity and are frequently associated with poor prognosis, particularly in high-risk patients. The cornerstones in the management of complicated IAIs are timely effective source control with appropriate antimicrobial therapy. Empiric antimicrobial therapy is important in the management of intra-abdominal infections and must be broad enough to cover all likely organisms because inappropriate initial antimicrobial therapy is associated with poor patient outcomes and the development of bacterial resistance. The overuse of antimicrobials is widely accepted as a major driver of some emerging infections (such as C. difficile), the selection of resistant pathogens in individual patients, and for the continued development of antimicrobial resistance globally. The growing emergence of multi-drug resistant organisms and the limited development of new agents available to counteract them have caused an impending crisis with alarming implications, especially with regards to Gram-negative bacteria. An international task force from 79 different countries has joined this project by sharing a document on the rational use of antimicrobials for patients with IAIs. The project has been termed AGORA (Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections). The authors hope that AGORA, involving many of the world's leading experts, can actively raise awareness in health workers and can improve prescribing behavior in treating IAIs.

• MeSH
• antibiotická rezistence MeSH
• antiinfekční látky farmakologie   MeSH
• lidé MeSH
• mezinárodní spolupráce * MeSH
• mikrobiální testy citlivosti MeSH
• nitrobřišní infekce * diagnóza   farmakoterapie   mikrobiologie   MeSH
• prognóza MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH
• Názvy látek
• antiinfekční látky MeSH